Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
J1-09B
Québec, QC
Canada G1S 4L8
63 entries « 3 of 7 »

Guertin JR, Ferrari N, Gagné V, Truchon C, de Guise M

Utilisation de l’oxygénation extracorporelle par membrane chez l’adulte au Québec Rapport complémentaire : Évaluation des coûts intrahospitaliers

Book

INESSS, Québec, 2019, ISBN: 9782550839491.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Tarride JE

Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study

Journal Article

CMAJ Open, 7 (3), 2019.

Abstract | Links:

Muratov S, Lee J, Holbrook A, Guertin JR, Mbuagbaw L, Paterson JM, Gomes T, Pequeno P, Tarride JE

Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study

Journal Article

BMJ Open, 9 (10), 2019.

Abstract | Links:

Fillion V, Sirois MJ, Gamache P, Guertin JR, Morin SN, Jean S

Frailty and health services use among Quebec seniors with non-hip fractures: a population-based study using adminsitrative databases

Journal Article

BMC Health Serv Res, 19 (1), 2019.

Abstract | Links:

Fanton-Aita F, Matteau A, Potter BJ, Guertin JR, Mitchell D, Iliza AC, Dubois A, Dubé MP, Tardif JC, LeLorier J

Framework for the cost-effectiveness of secondary prevention strategies in cardiovascular diseases: A Canadian theoretical model-based analysis

Journal Article

1 (1), 2018.

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada

Journal Article

Clinicoecon Outcomes Res, 10 , 2018.

Abstract | Links:

Guertin JR, Pagé MG, Tarride JÉ, Talbot D, Watt-Watson J, Choinière M

Just how much does it cost? A cost study of chronic pain following cardiac surgery

Journal Article

J Pain Res, 11 , 2018.

Abstract | Links:

Tarride JE, Smofsky A, Nykoliation P, Allain S, Lewis-Daly L, Satok D, Schwartz J, Pollack JH, Guertin JR, McIntyre RS

Effectiveness of a Type 2 Diabetes Screening Intervention in the Canadian Workplace

Journal Article

Can J Diabetes, 42 (5), 2018.

Abstract | Links:

Mitchell D, Guertin JR, LeLorier J

Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk

Journal Article

Mol Diagn Ther, 22 (6), 2018.

Abstract | Links:

Mitchell D, Guertin JR, Dubois A, Dube MP, Tardif JC, Iliza AC, Fanton-Aita F, Matteau A, LeLorier J

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention

Journal Article

Mol Diagn Ther, 22 (2), 2018.

Abstract | Links:

63 entries « 3 of 7 »
Signaler des ajouts ou des modifications

Active projects

  • Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, from 2020-04-01 to 2023-03-31
  • Clinical validity and clinical utility of a screening test for Paget's disease of bone, from 2019-03-01 to 2023-03-31
  • Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., from 2016-07-01 to 2024-03-31
  • Étude de l'éco-efficience du port de l'équipement de protection individuelle contre la COVID-19 dans les urgences pour un contexte post-pandémique, from 2021-10-01 to 2024-03-31
  • Étude préclinique et pharmacoépidémiologique de l’impact du dutastéride dans l’étiopathogenèse et la progression de la maladie de Parkinson, from 2021-04-01 to 2022-08-31
  • Fardeau économique des grands brûlés pour un centre hospitalier du Canada, from 2021-08-20 to 2023-09-01
  • How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, from 2018-10-01 to 2022-09-30
  • Infrastructure de l'évaluation économique en médecine régénératrice, from 2020-04-01 to 2023-03-31
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, from 2018-04-01 to 2024-03-31
  • Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly – A Causal Perspective to Treatment Trajectory Analysis, from 2019-10-01 to 2023-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2020-04-01 to 2024-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-10-01 to 2025-03-31

Recently finished projects

  • Canadian Program for Monitoring Overuse in Injury Care, from 2016-07-01 to 2021-06-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2022-02-28
  • Programme de soutien aux nouveaux chercheurs, from 2019-07-01 to 2022-06-30
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2022-03-31
  • Real-World Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation: A Canadian Health Technology Reassessment Study, from 2018-04-01 to 2020-09-30
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-03-01 to 2022-02-28
Data provided by the Université Laval research projects registery